Canaan Partners Xi LLC Tyra Biosciences, Inc. Transaction History
Canaan Partners Xi LLC
- $35.9 Million
- Q2 2025
A detailed history of Canaan Partners Xi LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Canaan Partners Xi LLC holds 3,608,109 shares of TYRA stock, worth $38.2 Million. This represents 96.23% of its overall portfolio holdings.
Number of Shares
3,608,109
Previous 4,144,590
12.94%
Holding current value
$38.2 Million
Previous $40.5 Million
14.73%
% of portfolio
96.23%
Previous 95.26%
Shares
4 transactions
Others Institutions Holding TYRA
# of Institutions
120Shares Held
59.8MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$129 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$43.3 Million93.82% of portfolio
-
Nextech Invest Ag4.06MShares$43 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$43 Million7.35% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$41.8 Million1.48% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $445M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...